These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3484535)

  • 21. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: characterization and localization of receptor binding sites in rat and human brain.
    Javitch JA; Uhl GR; Snyder SH
    Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4591-5. PubMed ID: 6611553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs with potent nigrostriatal toxicity for potential use in positron emission tomography studies.
    Harik SI; Riachi NJ; Hritz MA; Berridge MS; Sayre LM
    J Pharmacol Exp Ther; 1993 Aug; 266(2):790-5. PubMed ID: 8355208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity by the novel selective dopamine D3-receptor partial agonist FAUC 329 predominantly in the nucleus accumbens of mice.
    Boeckler F; Leng A; Mura A; Bettinetti L; Feldon J; Gmeiner P; Ferger B
    Biochem Pharmacol; 2003 Sep; 66(6):1025-32. PubMed ID: 12963489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experimental research on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian animal models in the rhesus monkey and C57 black mouse].
    Chen S
    Zhonghua Yi Xue Za Zhi; 1990 May; 70(5):252-4, 18. PubMed ID: 2168792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.
    Heikkila RE; Hess A; Duvoisin RC
    Science; 1984 Jun; 224(4656):1451-3. PubMed ID: 6610213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat.
    Harik SI; Schmidley JW; Iacofano LA; Blue P; Arora PK; Sayre LM
    J Pharmacol Exp Ther; 1987 May; 241(2):669-76. PubMed ID: 2437293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus.
    Mitchell IJ; Cross AJ; Sambrook MA; Crossman AR
    Neurosci Lett; 1985 Oct; 61(1-2):195-200. PubMed ID: 3878482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local cerebral metabolic effects of L-dopa therapy in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys.
    Porrino LJ; Burns RS; Crane AM; Palombo E; Kopin IJ; Sokoloff L
    Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5995-9. PubMed ID: 3497401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys.
    Chiueh CC; Burns RS; Markey SP; Jacobowitz DM; Kopin IJ
    Life Sci; 1985 Jan; 36(3):213-8. PubMed ID: 3871241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute administration of 1-N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a compound producing parkinsonism in humans, stimulates [2-14C]deoxyglucose uptake in the regions of the catecholaminergic cell bodies in the rat and guinea pig brains.
    Palacios JM; Wiederhold KH
    Brain Res; 1984 May; 301(1):187-91. PubMed ID: 6610458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Similar distribution of monoamine oxidase (MAO) and parkinsonian toxin (MPTP) binding sites in human brain.
    Reznikoff G; Manaker S; Parsons B; Rhodes CH; Rainbow TC
    Neurology; 1985 Oct; 35(10):1415-9. PubMed ID: 3875804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional and temporal expression of the peripheral benzodiazepine receptor in MPTP neurotoxicity.
    Kuhlmann AC; Guilarte TR
    Toxicol Sci; 1999 Mar; 48(1):107-16. PubMed ID: 10330690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
    Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD
    Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessment.
    Ricaurte GA; Langston JW; Delanney LE; Irwin I; Peroutka SJ; Forno LS
    Brain Res; 1986 Jun; 376(1):117-24. PubMed ID: 3487376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Normal MPTP binding in parkinsonian substantial nigra: evidence for extraneuronal toxin conversion in human brain.
    Uhl GR; Javitch JA; Snyder SH
    Lancet; 1985 Apr; 1(8435):956-7. PubMed ID: 2859415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.
    Calon F; Lavertu N; Lemieux AM; Morissette M; Goulet M; Grondin R; Blanchet PJ; Bédard PJ; Di Paolo T
    Synapse; 2001 Jun; 40(3):225-34. PubMed ID: 11304760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism.
    Markey SP; Johannessen JN; Chiueh CC; Burns RS; Herkenham MA
    Nature; 1984 Oct 4-10; 311(5985):464-7. PubMed ID: 6332988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective visualization of rodent locus ceruleus by a radiolabeled N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analog.
    Efange SM; Mash D; Hefti F; Kung HF; Billings J
    J Neurochem; 1989 Aug; 53(2):459-64. PubMed ID: 2787390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurotensin receptor binding sites in monkey and human brain: autoradiographic distribution and effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
    Quirion R; Welner S; Gauthier S; Bédard P
    Synapse; 1987; 1(6):559-66. PubMed ID: 2843996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes.
    Chiba K; Trevor AJ; Castagnoli N
    Biochem Biophys Res Commun; 1985 May; 128(3):1228-32. PubMed ID: 3873939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.